Troy R Torgerson

University of California, San Francisco

NIH Rank #2963
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.8M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#2,963
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.8M across 3 grants · National rank #2963.

Top grants by award amount

Troy R Torgerson's NIH grant portfolio, ranked by award amount.

  • 1R24AI184316-01R24
    Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity
    $1.8M
    award amount
  • 4UH3TR003908-03UH3
    Safety and Efficacy of Itacitinib in treatment of JAK/STAT pathway disorders with activating mutations
    $843.5K
    award amount
  • 5U19AI128914-09U19
    Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and Immunization
    $149.1K
    award amount

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of California, San Francisco
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2963
  6. 2024
    Entered Top 25% Nationally
    Ranked #2963
  7. 2024
    Multi-Institutional Research
    Awards at 3 institutions